The myelodysplastic syndromes in 1996: Complex stem cell disorders confounded by dual actions of cytokines

Leukemia Research

Volumn 20, Issue 11-12, 1996, Pages 881-890

  Raza, Azra ^a   Gregory, Stephanie A ^a   Preisler, Harvey D ^a  

^a RUSH CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; PHOSPHOLIPID;

APOPTOSIS; BONE MARROW CELL; CELL PROLIFERATION; CELL TRANSFORMATION; CYTOPENIA; EDITORIAL; GENE MUTATION; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HUMAN; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; SECOND MESSENGER; SIGNAL TRANSDUCTION;

ACUTE DISEASE; APOPTOSIS; BONE MARROW; CELL CYCLE; CELL DIVISION; CELL TRANSFORMATION, NEOPLASTIC; CLONE CELLS; CYTOKINES; DISEASE PROGRESSION; HEMATOPOIETIC STEM CELLS; HUMANS; LEUKEMIA, MYELOID; MODELS, BIOLOGICAL; MYELODYSPLASTIC SYNDROMES; SIGNAL TRANSDUCTION;

EID: 0030293115     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0145-2126(96)00027-6     Document Type: Editorial

References (77)

1. 1. Bennett J. M., Catovsky D., Flandrin D. M. T., Galton G. D. A. G., Gralnick H. R. & Sultan C. (1982) Proposal for the classification of the myelodysplastic syndromes. Br. J. Haematol. 51, 189.
2. 2. Resegotti L. (1993) The nature and natural history of myelodysplasia. Haematologica 25, 191.
3. 3. Verhoef G. E. G., Pittaluga S., Wolf-Peeters C. De. & Boogaerts M. A. (1995) FAB classification of myelodysplastic syndromes: merits and controversies. Ann. Hematol. 71, 3.
4. 4. Stone R. M., Neuberg D., Soiffer R., Takovian T., Whelan M., Rabinove S. N., Aster J. C., Leavitt P., Manch P., Freedman A. S. & Nadler L. M. (1994) Myelodysplastic syndrome as a late complication following autologous bone marrow transplantation for non-Hodgkin's lymphoma. J. clin. Oncol. 12, 2535.
5. 5. Mulder N. H., Mulder P. O., Sleijfer D. T., Willemse P. H., Van der Ploeg E., Dolsma W. V. & Vries E. G. de (1993) Induction chemotherapy and intensification with autologous bone marrow reinfusion in patients with locally advanced and disseminated breast cancer. Eur. J. Cancer 29A, 668.
6. 6. Preisler H. D., Early A., Raza A., Vlahides G., Marinello M. J., Browman G., Vlahides G., Marinello M. J. & Stein A. M. (1983) Therapy of secondary acute non-lymphocytic leukemia with cytarabine. New Engl. J. Med. 308, 21.
7. 7. Raza A., Preisler H. D., Li Y. Q., Larson R., Goldberg J., Browman G., Bennett J., Grunwald H., Vogler R. & Kukla C. (1993) Biological characteristics of newly diagnosed poor prognosis acute myelogenous leukemia. Am. J. Hematol. 42, 359.
8. 8. Mitrous P. S. & Fischer M. (1979) Cell proliferation in refractory anemia with hyperplastic bone marrow (preleukemia). In Preleukemia (Schmalzl F. & Hellreigel K.P., Eds), p. 78.
9. 9. Hast R. & Reizenstein P. (1977) Studies on human leukemia. 1. Erythroblast and iron kinetics in a refractory anemia with hypercellular bone marrow. Scand. J. Haematol. 19, 347.
10. 10. Seigneur D. & Hallard D. (1981) Use of the tritiated thymidine-labeling index of the myeloblast-promyelocyte pool for the identification of the leukemic population of oligoblastic leukemia. Acta Haematologica 66, 181.
11. 11. Karsdorf A., Dresch C., Metral J. & Najean Y. (1983) Prognostic value of the combined suicide level of granulocyte progenitors in the labeling index of precursois in preleukemic state and oligoblastic leukemias. Leukemia Res. 7, 279.
12. 12. Hiddemann W., Buchner T., Andreef M., Warmann B., Melamed M. & Clarksan B. D. (1982) Bone marrow biopsy instead of 'marrow juice' for cell kinetic analysis: comparison of bone marrow biopsy and aspiration material. Leukemia Res. 6, 601.
13. 13. Holdrinet R. S. G., Van Egmond J., Wesse J. M. C. & Haaneu C. (1980) A method for quantification of peripheral blood admixture in bone marrow aspirates. Exp. Hematol. 8, 103.
14. 14. Raza A., Yousuf N., Bokhari S. A. J., Mehdi A., Masterson M., Lampkin B., Yanik G., Mazewski C., Khan S. & Preisler H. D. (1992) Contribution of invivo proliferation/ differentiation studies towards the development of a combined functional and morphologic system of classification of neoplastic disease. Cancer 69, Suppl. 6, 1557.
15. 15. Raza A., Bokahari J., Yousuf N., Mehdi A., Mazewski C., Khan S., Baker V. & Lampkin B. (1991) Cell cycle kinetic studies in human cancers: development of three DNA-specific labels in three decades. Arch. Pathol. lab. Med. 115, 873.
16. 16. Hibner U. & Coutinho A. (1994) Signal antonymy: a mechanism for apoptosis induction. Cell Death Differ. 1, 33.
17. 17. Montecucco C., Riccardi A. & Traversi E. (1983) Flow cytometric DNA content in myelodysplastic syndromes. Cytometry 4, 238.
18. 18. Peters S. W., Clark R. E., Hoy T. G. & Jacobs A. (1986) DNA content and cell cycle analysis of bone marrow cells in myelodysplastic syndromes. Br. J. Haematol. 62, 239.
19. 19. Yoshida Y. (1993) Apoptosis may be the mechanism responsible for the premature intramedullary cell death in myelodysplastic syndromes. Leukemia 7, 144.
20. 20. Clark D. M. & Lampert I. A. (1990) Apoptosis is a common histopathological finding in myelodysplasia: The correlate of ineffective hematopoiesis. Leukemia Lymphoma 2, 415.
21. 21. Wijsman J. H., Jonker R. R., Keijzer R., Van de Velde C. J. H., Cornelisse C. J. & Dierendonck J. H. V. (1993) A new method to detect apoptosis in paraffin sections: in situ end-labeling of fragmented DNA. J. Histochem. Cytochem. 41, 7.
22. 22. Gavrieli Y., Sherman Y. & Ben-Sasson S. A. (1992) Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol. 119, 491.
23. 23. Mundle S., Iftikhar A., Shetty V., Alvi S., Dameron S., Gregory S., Marcus B., Khan S. & Raza A. (1994) In situ end labeling of DNA to detect apoptotic cell death in a variety of human tumors. Cell Death Differ. 1, 117.
24. 24. Shetty V., Mundle S., Sanoy A., Sanghvi R., Loew J., Marcus B., Showel J., Gregory S. & Raza A. (1995) A multivariate study of non-Hodgkin's lymphoma involving proliferation, apoptosis, bcl-2 and the microenvironment. Leukemia Lymphoma 18, 273.
25. 25. Mundle S., Iftikhar A., Shetty V., Dameron S., Wright-Quinones V., Marcus B., Loew J., Gregory S. & Raza A. (1994) Novel in situ double-labeling for simultaneous detection of proliferation and apoptosis. J. Histochem. Cytochem. 42, 1533.
26. 26. Raza A., Mundle S., Iftikhar A., Gregory S., Marcus B., Khan Z., Alvi S., Shetty V., Dameron S., Wright V., Adler S., Loew J., Shott S., Ali N. & Preisler H. (1995) Simultaneous assessment of cell kinetics and programmed cell death in bone marrow biopsies of myelodysplastics reveals extensive apoptosis as the probable basis for ineffective hematopoiesis. Am. J. Hematol. 48, 143.
27. 27. Raza A., Gezer S., Mundle S., Gao X.-Z., Alvi S., Borok R., Rifkin S., Iftikhar A., Shetty V., Parcharidou A., Loew J., Marcus B., Khan Z., Chaney C., Showel J., Gregory S. & Preisler H. (1995) Apoptosis in bone marrow biopsy samples involving stromal and hematopoietic cells in 50 patients with myelodysplastic syndromes. Blood 86, 268.
28. 28. Mundle S. & Raza A. (1995) The two in situ techniques do not differentiate between apoptosis and necrosis but rather reveal distinct patterns of DNA fragmentation in apoptosis [Correspondence]. Lab. Invest. 72, 611.
29. 29. Huang P., Robertson L. E., Wright S. & Plunkett W. (1995) High molecular weight DNA fragmentation: a critical event in nucleoside analogue-induced apoptosis in leukemia cells. Clin. Cancer Res. 1, 1005.
30. 30. Alvi S., Borok R., Mundle S., Gao X.-Z., Shetty V., Hines C., Robin E., Rifkin S., Klein M., Alston D., Hernandez B., Hsu W.-T., Gezer S., Gregory S. & Raza A. (1995) Detection of high molecular weight DNA as evidence of apoptosis in myelodysplasia, abstract no. 1324. Proc. Am. Soc. Hematol. Blood 86, 334.
31. 31. Shetty V., Mundle S., Alvi S., Showel M., Broady-Robinson L., Dar S., Borok R., Showel J., Gregory S., Rifkin S., Gezer S., Parcharidou A., Venugopal P., Shah R., Hernandez B., Klein M., Alson D., Robin E., Dominquez C. & Raza A. (1996) Measurement of apoptosis, proliferation and three cytokines in 46 patients with myelodysplastic syndromes. Leukemia Res. 20, 891.
32. 32. Mundle S., Alvi S., Dong L.-M., Gezer S., Venugopal P., Hines C., Gregory S., Robin E., Rifkin S., Klein M., Alston D., Hernandez B., Hsu W.-T., Shetty V. & Raza A. (1995) Interleukin 1β converting enzyme-like protease may be involved in the intramedullary apoptotic death in the marrows of patients with myelodysplasia, abstract no. 1323. Proc. Am. Soc. Hematol., 37th Annual Meeting. Blood 86, 334a.
33. 33. Killman S. A. (1968) Acute leukemia: the kinetics of leukemic blast cells in man. An analytical review. Ser. Hematol. 1, 38.
34. 34. Weimar I. S., Bourhis J.-H., Gast G. C. D. & Gerristen W. R. (1993) Clonality in myelodysplastic syndromes. Leukemia Lymphoma 13, 215.
35. 35. Raskind W. H., Tirumali N., Jacobson R., Singer J. & Fialkow P. J. (1984) Evidence for a multistep pathogenesis of a myelodysplastic syndrome. Blood 63, 1318.
36. 36. Tefferi A., Thibodeau S. N. & Solberg L. A. Jr. (1990) Clonal studies in the myelodysplastic syndrome using X-linked restriction fragment length polymorphisms. Blood 75, 1770.
37. 37. Abrahamson G., Boultwood J., Madden J., Kelly S., Oscier D. G., Rack K., Buckle V. J. & Wainscoat J. S. (1991) Clonality of cell populations in refractory anemia using combined approach of gene loss and X-linked restriction fragment length polymorphism-methylation analyses. Br. J. Haematol. 79, 550.
38. 38. Okada M., Okamoto T., Kanamaru A. & Kaishita E. (1995) Clonal analysis in MDS (refractory anemia) by FISH and X-chromosome inactivation pattern using PCR. Proc. Am. Soc. Hematol. Blood 86, Suppl. 1, 3183a.
39. 39. Delforge M., Duppen V. V., Demuynck H., Verhoef G. E. G., et al. (1995) Clonality study of hematopoietic marrow progenitors and mature blood cells in female patients with myelodysplastic syndromes. Proc. Am. Soc. Hematol. Blood 86, Suppl. 1, 1328a.
40. 40. Prchal J. T., Throckmorton D. W., Carroll III A. J., Fuson E. W., Gams R. A. & Prchal J. F. (1978) A common progenitor for human myeloid and lymphoid cells. Nature 274, 590.
41. 41. Janssen J. W. G., Buschle M., Layton M., Drexler H. G., Lyons J., Berghe H. van den, Heimpel H., Kubanek B., Kleihauer E., Mufti G. J. & Bartram C. R. (1989) Clonal analysis of myelodysplastic syndromes: evidence of multipotent stem cell origin. Blood 73, 248.
42. 42. Delforge M., Demuynck H., Vandenberghe P., Verhoef G., Zachee P., Duppen V. V., Marijnen P., Berghe H. van den & Boogaerts M. A. (1995) Polyclonal primitive hematopoietic progenitors can be detected in mobilized peripheral blood from patients with high-risk myelodysplastic syndromes. Blood 86, 3660.
43. 43. Okamoto T., Okada M., Takatsuka H., Kamanaru A. & Kakishita E. (1995) Clonality of B-lymphocytes in myelodysplastic syndromes with autoimmune disease. Proc. Am. Soc. Hematol. Blood 86, Suppl. 1, 3184a.
44. 44. Van Kamp H., Fibbe W. E., Jansen R. P. M., Keur M. van der, deGraaff E., Willemze R. & Landegent J. E. (1992) Clonal involvement of granulocytes and monocytes but not of T and B lymphocytes and natural killer cells in patients with myelodysplasia: analysis by X-linked restriction fragment length polymorphisms and polymerase chain reaction of the phosphoglycerate kinase gene. Blood 80, 1774.
45. 45. Counter C. M., Gupta J., Harley C. B., Leber B. & Bacchetti S. (1995) Telomerase activity in normal leukocytes and hematologic malignancies. Blood 85, 2315.
46. 46. Kim N. W., Piatyszek M. A., Prowse K. R., Harley C. B., West M. D., Ho P. L. C., Coviello G. M., Wright W. E., Weinrich S. L. & Shay J. W. (1994) Specific association of human telomerase activity with immortal cells and cancer. Science 266, 2011.
47. 47. Heim S. (1992) Cytogenetic findings in primary and secondary MDS. Leukemia Res. 16, 43.
48. 48. Willman C. L., Sever C. E., Pallavicini M. G., Harada H., Tanaka N., Slovak M. L., Yamamoto H., Harada K., Meeker T. C., List A. F. & Taniguchi T. (1993) Deletion of IRF-1 mapping to chromosome 5q31.1 in human leukemia and preleukemic myelodysplasia. Science 259, 986.
49. 49. Boultwood J., Fidler C., Lewis S., McCarthy A., Sheridan H., et al. (1993) Allelic loss of IRF-1 in myelodysplasia and acute myeloid leukemia: retention of IRF-1 on the 5q-chromosome in some patients with 5q-syndrome. Blood 82, 2611.
50. 50. Harada H., Kitagawa N., Tanaka N., Yamamoto H., Harada K., Ishihara M. & Taniguchi T. (1993) Anti-oncogenic and oncogenic potentials of interferon regulatory factors-1 and 2 (reprinted from 1974). Science 259, 971.
51. 51. Harada H., Kondo T., Ogawa S., Tamura T., Kitagawa M., Tanaka N., Lamphier M. S., Hirai H. & Taniguchi T. (1994) Accelerated exon skipping of IRF-1 mRNA in human myelodysplasia, leukemia: a possible mechanism of tumor suppressor inactivation. Oncogene 9, 3313.
52. 52. Abdollahi A., Lord K. A., Hoffman-Liebermann B. & Liebermann D. A. (1991) Interferon regulatory factor 1 is a myeloid differentiation primary response gene induced by IL6 and leukemia inhibitory factor: role in growth inhibition. Cell Growth Differ. 2, 401.
53. 53. Harada H., Takahashi E., Ioh S., Harada K., Hori T. A. & Taniguchi T. (1994) Structure and regulation of the human interferon regulatory factor 1 (IRF-1) and IRF-2 genes. Implications for a gene network in the interferon system. Molec. Cell Biol. 14, 1500.
54. 54. Mucenski M. L., Taylor B. A., Ihle J. N., Hartley J. W., Morse H. C. III, Jenkins N. A. & Copeland N. G. (1988) Identification of a common ecotropic viral integration site Evi-1 in the DNA of AKXD murine tumors. Molec. Cell Biol. 8, 301.
55. 55. Morishita K., Parganas E., Willman C. L., Whittaker M. H., Drabkin H., Oval J., Taetle R., Valentine M. B. & Ihle J. N. (1992) Activation of Evi-1 gene expression in human acute myelogenous leukemias by translocations spanning 300-400 kilobases on chromosome band 3q26. Proc. natn. Acad. Sci. U.S.A. 89, 3937.
56. 56. Bartram C. R. (1992) Molecular genetic aspects of myelodysplastic syndromes. Hematol. Oncol. Clin. Am. 6, 557.
57. 57. Jacobs A. (1992) Gene mutations in myelodysplasia. Leukemia Res. 16, 47.
58. 58. Stephenson J., Mufti G. J. & Yoshida Y. (1993) Myelo-dysplastic syndromes: from morphology to molecular biology, Part II. The molecular genetics of myelodysplasia. Int. J. Hematol. 57, 99.
59. 59. Golub T. R., Barker G. F., Lovett M. & Gilliland D. G. (1994) Fusion of platelet-derived growth factor β to a novel Ets-like gene, tel, in chronic myelomonocytic leukemia with t(5; 12) chromosomal translocation. Cell 77, 307.
60. 60. Mori N., Hidai H., Yokota J., Okada M., Motoji T., Oshimi K. & Mizoguchi H. (1995) Mutations of the p53 gene in myelodysplastic syndrome and overt leukemia. Leukemia Res. 19, 869.
61. 61. Ridge S. A., Worwood M., Oscier D., Jacobs A. & Padua R. A. (1990) Fms mutations in myelodysplastic, leukemic and normal subjects. Proc. natn. Acad. Sci. U.S.A. 87, 1377.
62. 62. Sheridan B. L. & Rels M. D. (1990) Oncogene involvement in myelodysplasia and acute myeloid leukemia. Tumor Biol. 1, Suppl 1, 44.
63. 63. Westbrook C. A., LeBeau M. M., Neuman W. I., Keinanen M., Yamaoka L. H., Speer M. C., Espinosa III R., Nakamura Y., Williamson R., Mullan M. & Buetow K. (1994) Physical and genetic map of 5q 31: use of fluorescence in situ hybridization data to identify errors in the CEPH database. Cytogenet. cell. Genet. 67, 86.
64. 64. Kanter L., Hellstrom-Lindberg E., Kock Y., Rodensjo M. & Ost A. (1995) Erythropoietic effectiveness and apoptosis in patients with myelodysplastic syndromes treated with G-CSF and Epo. Proc. Am. Soc. Hematol. Blood 86, Suppl. 1, 1339.
65. 65. Parcharidou A., Raza A., Economopoulos T., Papageorgiou E., Anagnostou D., Papadaki T. & Stamatopoulos K. (1995) Extensive apoptosis of bone marrow cells as evaluated by the in situ end labelling (ISEL) technique may be the basis for ineffective hematopoiesis in patients with myelodysplastic syndromes. Proc. Am. Soc. Hematol. Abstract no. 3185. Blood 86, Suppl. 1, 799.
66. + cells. Blood 85, 194.
67. 67. Mayani H., Baines P., Bowen D. T. & Jacobs A. L. (1989) In vitro growth of myeloid and erythroid progenitor cells from myelodysplastic patients in response to recombinant human granulocyte-macrophage colony stimulating factor. Leukemia 3, 29.
68. 68. Asano H., Hotta T., Ichihara M., et al. (1994) Growth analysis of marrow CD34 positive hemopoietic progenitor cells in patients with myelodysplastic syndromes. Leukemia 8, 833.
69. 69. Coutinho L. H., Geary C. G., Chang J., Harrison C. & Testa N. G. (1990) Functional studies of bone marrow haemopoietic and stromal cells in the myelodysplastic syndrome (MDS). Br. J. Haematol. 75, 16.
70. 70. Ganser A., Jansen J. W. G., Offman O. G., Seipett G., Eder M., Becher R., Lindermann A., Hesrmann F., Schulz G., Mertelsmann R., Hoelzer D. & Bartman C. R. (1991) In vivo effects of GM-CSF and IL-3 on clonal and non-clonal cell populations in patients with clonal hematopoietic disorders. Leukemia 5, 487.
71. 71. Ito T., Ohashi H., Kagami Y., Ichikawa A., Saito H. & Hotta T. (1994) Recovery of polyclonal hematopoiesis in patients with myelodysplastic syndromes following successful chemotherapy. Leukemia 8, 839.
72. 72. Bursten S., Weeks R., West J., Le T., Wilson T., Porubeck D., Bianco J. A., Singer J. W. & Rice G. C. (1994) A potential role for phosphatidic acid in mediating the inflammatory responses of TNF-α and IL-1. Circ. Shock 44, 14.
73. 73. Abraham E., Burstein S., Shemkar R., Allbee J., Tuder R., Woodson P., Guidot D. M., Rice G. C., Singer J. W. & Repine J. E. (1995) Phosphatidic acid signalling mediates lung cytokine expression and lung inflammatory injury after hemorrhage in mice. J. exp. Med. 181, 569.
74. 74. Clark E., Rice G. C., Weeks R. S., Jenkins N., Nelson R., Bianco J. A. & Singer J. W. (1996) Lisophylline inhibits TGF-β release and enhances trilineage hematopoietic recovery after 5-FU treatment in mice. Cancer Res. 56, 105.
75. 75. Rice G. C., Rosen J. W., Weeks R., Michnik J., Bianco J. A. & Singer J. W. (1994) CT-1501R selectively inhibits induced inflammatory monokines in human whole blood ex vivo. Shock 1, 254.
76. 76. Rice G. C., Brown P. A., Nelson R. J., Bianco J. A., Singer J. W. & Bursten S. (1994) Protection from endotoxic shock in mice by pharmacologic inhibition of phosphatidic acid. Proc. natl. Acad. Sci. U.S.A. 91, 3857.
77. 77. Ward A. & Clossold S. P. (1987) Pentoxifylline: a review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy. Drugs 34, 50.